Works matching IS 10600280 AND DT 2014 AND VI 48 AND IP 3
Results: 26
Response to 'proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?'.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Comments on 'proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?'.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Reply to Comments on 'Subtherapeutic Linezolid Concentrations in a Patient With Morbid Obesity and Methicillin-Resistant Staphylococcus aureus Pneumonia: Case Report and Review of the Literature'.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Comments on Linezolid in Morbid Obesity.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 429, doi. 10.1177/1060028013518901
- By:
- Publication type:
- Article
Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-1 Infection.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Response to "Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?".
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 432, doi. 10.1177/1060028013512832
- By:
- Publication type:
- Article
Comments on "Proton Pump Inhibitor-Associated Hypomagnesemia: What Do FDA Data Tell Us?".
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 431, doi. 10.1177/1060028013512831
- By:
- Publication type:
- Article
Reply to Comments on "Subtherapeutic Linezolid Concentrations in a Patient With Morbid Obesity and Methicillin-Resistant Staphylococcus aureus Pneumonia: Case Report and Review of the Literature".
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 430, doi. 10.1177/1060028013517662
- By:
- Publication type:
- Article
Early Symptom Improvement and Discontinuation of 5-[alpha]-Reductase Inhibitor (5ARI) Therapy in Patients With Benign Prostatic Hyperplasia (BPH)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Erythema Multiforme Secondary to Dimenhydrinate in a Patient With Previous Similar Reactions to Pamabrom.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 425, doi. 10.1177/1060028013518728
- By:
- Publication type:
- Article
Fondaparinux as Alternative Anticoagulant to Warfarin or Low-Molecular-Weight Heparin for Recurrent Venous Thrombosis.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 420, doi. 10.1177/1060028013519753
- By:
- Publication type:
- Article
Collaborative Practice Model Between Cardiologists and Clinical Pharmacists for Management of Patients With Cardiovascular Disease in an Outpatient Clinic.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 412, doi. 10.1177/1060028013515432
- By:
- Publication type:
- Article
MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 404, doi. 10.1177/1060028013514375
- By:
- Publication type:
- Article
Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-I Infection.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 395, doi. 10.1177/1060028013513558
- By:
- Publication type:
- Article
Vandetanib for the Treatment of Medullary Thyroid Carcinoma.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 387, doi. 10.1177/1060028013512791
- By:
- Publication type:
- Article
Approach to Antimicrobial Prophylaxis for Urology Procedures in the Era of Increasing Fluoroquinolone Resistance.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 380, doi. 10.1177/1060028013517661
- By:
- Publication type:
- Article
Pediatric Exclusivity: Evolving Legislation and Novel Complexities within Pediatric Therapeutic Development.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 369, doi. 10.1177/1060028013514031
- By:
- Publication type:
- Article
Comparing Dosing of Basal Insulin Analogues Detemir and Glargine: Is It Really Unit-Per-Unit and Dose-Per-Dose?
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 361, doi. 10.1177/1060028013518420
- By:
- Publication type:
- Article
Evaluation of Dabigatran Exposures Reported to Poison Control Centers.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 354, doi. 10.1177/1060028013513883
- By:
- Publication type:
- Article
Evaluation of Dabigatran Utilization and Risk Among Hospitalized Patients.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 349, doi. 10.1177/1060028013513722
- By:
- Publication type:
- Article
Early Symptom Improvement and Discontinuation of 5-α-Reductase Inhibitor (5ARI) Therapy in Patients With Benign Prostatic Hyperplasia (BPH).
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 343, doi. 10.1177/1060028013514213
- By:
- Publication type:
- Article
Association of Fentanyl With Neurodevelopmental Outcomes in Very-Low-Birth-Weight Infants.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 335, doi. 10.1177/1060028013514026
- By:
- Publication type:
- Article
Early Pharmacological Treatment of Delirium May Reduce Physical Restraint Use: A Retrospective Study.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 328, doi. 10.1177/1060028013513559
- By:
- Publication type:
- Article
Evaluation of Impact of Statin Use on Development of CPK Elevation During Daptomycin Therapy.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 320, doi. 10.1177/1060028013514377
- By:
- Publication type:
- Article
Intravenous Metoprolol Versus Diltiazem for Rate Control in Noncardiac, Nonthoracic Postoperative Atrial Fibrillation.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 314, doi. 10.1177/1060028013512473
- By:
- Publication type:
- Article
Quantitative Drug Benefit-Risk Assessment: Utility of Modeling and Simulation to Optimize Drug Safety in Older Adults.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 3, p. 306, doi. 10.1177/1060028013514376
- By:
- Publication type:
- Article